Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

DNAPC4ImunoMol DNA modules as communicators in tumor immunomodulation

Coordinator
Johannes Gutenberg-Universitat Mainz, Germany
Runs
1 May 2023 to 30 April 2025
Status
Running
EU funding
€174k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101111348

What the project is doing

In the project's own words, from its summary on CORDIS.

Our goal is to develop all-DNA structures (protocells) that can act as modulators of the immune system and, in particular, of signaling processes in oncology. Molecular DNA switches that interact with cells via aptamers have been developed and used for drug delivery, cell imaging, and potential therapies. However, there are several advantages of incorporating these swithces into protocells, such as the protection of these circuits against degradation, the ability to create gradients and as a delviery method for in vivo application.

DNA protocells that (i) have the ability to recognize proteins and small molecules and (ii) amplify signals and generate output that alters cell physiology have not yet been developed. Realizing these structures requires filling a gap in our knowledge of how of how aptamer reactions network in confinement. We anticipate that by filling these gaps in our knowledge, we will be able to produce a pure DNA protocell that can harbor aptamer-based response networks for modulation of intercelullar communication in the tumor microenvironment.

Topics

Who is involved

OrganisationCityCountryRole
Johannes Gutenberg-Universitat MainzMainzGermanyCoordinator
City College of the City University of New YorkNew York, NyUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI